EUVIMEDEUVIMED entdecken
Crossref

Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells)

Sahar Mohajeri iD, Hashem Yaghoubi iD, Shima Bourang, Mehran Noruzpour

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04381-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sahar Mohajeri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Ard.C., Islamic Azad University, Ardabil, Iran. sahar.mohajeri@iau.ac.ir. Hauptthemen laut MEDLINE: RNA, Small Interfering, Paclitaxel, Nanocapsules, Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 100 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The targeted delivery of nucleic acids and drugs via nanoparticles to damaged cells remains a significant challenge in cancer treatment. This study focused on the bipolar copolymer Fe3O4/chitosan/polycaprolactone (PCL)/polyethylene glycol (PEG)-hyaluronic acid (HA) nanocapsules designed to enhance drug delivery to CD44 receptor-expressing MCF-7 cancer cells. These nanoparticles integrate iron oxide, hydrophilic PEG, biodegradable PCL, cationic chitosan, and hyaluronic acid. The physicochemical properties of the nanoparticles were investigated and confirmed via Fourier transform infrared (FTIR) spectroscopy and differential thermogravimetric (DTG) analysis. After paclitaxel (PTX) and siRNA-FAM loading, the zeta potential, dynamic light scattering (DLS), and scanning electron microscopy (SEM) confirmed the successful synthesis and appropriate structural properties of the nanocapsules. The nanocapsules were measured at approximately 230 nm with a zeta potential of - 2.5 mV. Release studies at pH 5 and 7.4 demonstrated that a lower pH significantly increased the release rates of PTX and siRNA-FAM. Electrophoretic analysis indicated that the nanocapsule coating (controlled-release nanoprotective coating) protected these agents from plasma degradation. An evaluation of the magnetic properties via a vibrating sample magnetometer (VSM) revealed that the iron oxide nanoparticles exhibited desirable magnetic characteristics, with values decreasing from 42.5 to 16.8 emu/g upon encapsulation. Cytotoxicity assessments via the MTT assay indicated the low toxicity (IC50 = 492.7 μg/mL) of the nanocapsules to the MCF-7 cell line. Flow cytometry revealed effective targeted gene transfer, with significant pre- and post-apoptosis rates (18.14% and 15.65%, respectively) for the Fe3O4/chitosan/PCL/PEG-HA/PTX treatment. The agarose gel and fluorescence microscopy results confirmed the superior gene transfer efficiency of the Fe3O4/chitosan/PCL/PEG-HA/siRNA-FAM nanocapsules compared with the controls, which was attributed to their stability and the presence of hyaluronic acid groups. This study presents the first application of these nanocapsules for gene and drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingPaclitaxelNanocapsulesBreast NeoplasmsMagnetite NanoparticlesDrug Delivery SystemsAntineoplastic Agents, PhytogenicHumansMCF-7 CellsHyaluronic AcidChitosanPolyestersPolyethylene GlycolsFemaleDrug LiberationCell Survival

Stichwörter der Autor:innen

ApoptosisDrug deliveryMagnetic nanoparticlesNanocapsulesTargetingZeta potential

Substanzen

RNA, Small InterferingPaclitaxelNanocapsulesHyaluronic AcidChitosanPolyestersPolyethylene GlycolspolycaprolactoneMagnetite NanoparticlesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Chemistry, Ard.C., Islamic Azad University, Ardabil, Iran. sahar.mohajeri@iau.ac.ir.
  • Department of Biology, Ard.C., Islamic Azad University, Ardabil, Iran. yaghoubi_h@iau.ac.ir.
  • Department of Agronomy and Plant Breeding, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Ardabil, Iran.

ORCID-Profile: Sahar Mohajeri, Hashem Yaghoubi

Zitieren

APA

Mohajeri, S., Yaghoubi, H., Bourang, S., & Noruzpour, M. (2025). Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04381-8

Vancouver

Mohajeri S, Yaghoubi H, Bourang S, Noruzpour M. Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04381-8

BibTeX
@article{Mohajeri2025,
  author = {Mohajeri, Sahar and Yaghoubi, Hashem and Bourang, Shima and Noruzpour, Mehran},
  title = {Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells)},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04381-8}
}
Kostenlos starten →